Reduction of share capital
Please read the full announcement in the attached PDF Attachment 2022_12_Reduction_of_share_capital
News
Clover’s Efficacy Data in Previously-Infected Individuals is Published in Lancet Infectious Disease
--94% cumulative protective effect against COVID-19 in previously-infected individuals that subsequently received Clover’s COVID-19 vaccine candidate-- --First and only COVID-19...
FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-1, a Phase 3 Clinical Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis
- 356 IPF Patients Enrolled - - Topline Data Anticipated Mid-2023 - SAN FRANCISCO, April 20, 2022 (GLOBE NEWSWIRE) --...
Enochian BioSciences Announces the Appointment of Executive Vice President of Research and Development with 25 years of Industry Experience
LOS ANGELES, April 20, 2022 (GLOBE NEWSWIRE) -- Enochian BioSciences (NASDAQ: ENOB). Enochian BioSciences Inc., a company focused on gene-modified...
CareDx Showcases Leadership with Over 25 Oral Presentations and Posters at the International Society for Heart and Lung Transplantation Meeting
Data Highlights Clinical Utility of CareDx Solutions, Including Findings from Surveillance HeartCare Outcomes Registry (SHORE) Demonstrating Power of Multimodality Assessment...
Tonix Pharmaceuticals Announces Results of Retrospective Observational Database Study In Over 50,000 Long COVID Patients
Over 40% of Long COVID Patients Had Fibromyalgia-Like Multi-Site Pain Symptoms Rate of Opioid Use in Long COVID Patients with...
Trevena Announces Results from Respiratory Physiology Study of Head-to-Head Comparison of OLINVYK® and IV Morphine in Elderly/Overweight Subjects
OLINVYK showed a statistically significant reduced impact on respiratory function compared to IV morphine, among elderly/overweight subjects Data replicate observations...
Vistin Pharma ASA: Invitation to Q1 2022 conference call
Oslo, Norway, 20 April 2022 Vistin Pharma ASA will release its first quarter 2022 results on Wednesday 27th of April 2022....
COMPASS Pathways partners with One Mind to fund Rising Star Awards for the next generation of mental health researchers
London, UK – 20 April 2022 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to...
Oxford Biomedica Preliminary Results
Oxford Biomedica plcPreliminary results for the year ended 31 December 2021 Saving Lives Oxford, UK – 20 April 2022: Oxford...
XORTX Receives Small and Medium Enterprise Status for the European Union
CALGARY, Alberta, April 20, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX...
HOOKIPA Pharma Appoints Tim Reilly, Ph.D. to its Board of Directors
NEW YORK and VIENNA, Austria, April 20, 2022 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing...
Indaptus Therapeutics to Present at 2nd Annual Chronic HBV Drug Development Summit
NEW YORK, April 20, 2022 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company”) today announced that...
Windtree Announces Positive Topline Results from Its Phase 2 SEISMiC Study of Istaroxime in Early Cardiogenic Shock
Istaroxime significantly improved the systolic blood pressure profileWARRINGTON, Pa., April 20, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT),...
VantAI Forms Research Collaboration with Boehringer Ingelheim to Identify Novel Protein Degraders
Zachary Carpenter Zachary Carpenter, Ph.D., Founder and CEO of VantAIVantAI will pair its induced proximity platform with BI’s deep early...
Unite for Change Makes it Easy for Canadians to Take Action This Earth Day
Newly launched Unite for Change platform by CanadaHelps enables Canadians to drive meaningful change by supporting multiple charities through a...
CLS Americas and URN Announce First Patient Treated in Clinical Study “Targeted MRI/ US Fusion Transperineal Laser Ablation of Low-to-Intermediate Risk Prostate Cancer”
Minimally Invasive, Outpatient Treatment Designed for Office or ClinicIRVINE, Calif. and MIAMI, April 20, 2022 (GLOBE NEWSWIRE) -- CLS Americas,...
Indicative offer to acquire 100% of the share capital of RAMSAY HEALTH CARE LIMITED (RAMSAY GENERALE DE SANTE’S Australian reference shareholder)
PRESS RELEASEParis, April 20th 2022 INDICATIVE OFFER TO ACQUIRE 100% OF THE SHARE CAPITAL OF RAMSAY HEALTH CARE LIMITED (RAMSAY...
Bavarian Nordic Announces Initiation of a Global Phase 3 Clinical Trial of its RSV Vaccine Candidate in Older Adults
First subject vaccinated in Phase 3 clinical trial of MVA-BN® RSV against respiratory syncytial virus (RSV) in older adultsTrial will...
Liisa Hurme appointed President and CEO of Orion Corporation as of 1 November 2022
PHOTO: Liisa Hurme (Photographer: Orion/Miika Kainu) Liisa HurmeORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION20 APRIL 2022 at 8:30 a.m....
